Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings.
Profitability
This table compares Strata Skin Sciences and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Strata Skin Sciences | -35.64% | -476.73% | -33.49% |
| Innovative Eyewear | -216.76% | -102.66% | -92.20% |
Institutional & Insider Ownership
32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 1.8% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Volatility and Risk
Strata Skin Sciences has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.75, meaning that its share price is 175% more volatile than the S&P 500.
Earnings and Valuation
This table compares Strata Skin Sciences and Innovative Eyewear”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Strata Skin Sciences | $30.98 million | 0.00 | -$10.09 million | ($1.41) | N/A |
| Innovative Eyewear | $3.41 million | 2.08 | -$7.59 million | ($1.18) | -0.69 |
Innovative Eyewear has lower revenue, but higher earnings than Strata Skin Sciences. Innovative Eyewear is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Strata Skin Sciences and Innovative Eyewear, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Strata Skin Sciences | 1 | 0 | 0 | 0 | 1.00 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
Given Strata Skin Sciences’ higher possible upside, equities research analysts clearly believe Strata Skin Sciences is more favorable than Innovative Eyewear.
Summary
Strata Skin Sciences beats Innovative Eyewear on 7 of the 12 factors compared between the two stocks.
About Strata Skin Sciences
Strata Skin Sciences, Inc. is a medical technology company focused on developing and commercializing products for dermatology and aesthetic applications. Its portfolio is centered on light-based devices used by physicians to treat a range of skin conditions. The company’s principal products include the XTRAC excimer laser system, which is used in the treatment of psoriasis, vitiligo and other localized skin disorders, and the VTRAC excimer lamp system for similar dermatological applications. Strata also provides related treatment accessories, replacement components and support services for healthcare providers.
About Innovative Eyewear
Innovative Eyewear, Inc. is a technology and eyewear company that develops and sells smart glasses designed to combine traditional eyewear with wireless audio and hands-free digital functionality. Its products generally incorporate speakers, microphones and Bluetooth connectivity, allowing users to listen to music, make calls and interact with voice assistants while keeping their hands free. The company markets products under the Lucyd brand, including prescription-capable eyewear, sunglasses and blue-light-filtering styles.
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
